Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489].
Saved in:
| Title: | Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489]. |
|---|---|
| Authors: | Curtis, Sean P.1 sean_curtis@merck.com, Bockow, Barry2 barryb@seanet.com, Fisher, Chester3 drfisher@hrhr-inc.com, Olaleye, Joseph1 jolaleye@GCOus.jnj.com, Compton, Amy1 amy.compton@roche.com, Ko, Amy T.1 amy_ko@merck.com, Reicin, Alise S.1 alise_reicin@merck.com |
| Source: | BMC Musculoskeletal Disorders. 2005, Vol. 6, p58-10. 10p. 3 Graphs. |
| Database: | Academic Search Ultimate |
| ISSN: | 14712474 |
|---|---|
| DOI: | 10.1186/1471-2474-6-58 |
